Drug recall · January 23, 2019
EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg recall
Why: CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01
- Lots / codes
Lot #: S16E02, Exp 05/18
- Quantity
- 5,000 bottles
- Company
- Syntho Pharmaceuticals, Inc., Farmingdale, NY
- Distribution
- Product was sold to the firm's sole distributor who further distributed the product throughout the United States.
- Initiated
- April 17, 2017 · Voluntary: Firm initiated
- Classified
- January 16, 2019
- Reported
- January 23, 2019
- Ended
- March 27, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methyltestosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.